QSC Tirzepatide is a dual GIP and GLP-1 receptor agonist that has shown promising results in weight management research. This synthetic peptide is supplied as a white powder with high purity (99%+) for research applications.
As a GLP-1 receptor agonist, QSC Tirzepatide works by helping regulate blood sugar levels and promoting satiety. Research suggests it may help with weight management through multiple mechanisms including slowing gastric emptying and reducing appetite.
Our QSC Tirzepatide is produced under strict quality control standards and is suitable for research purposes only. The product is supplied in vials with proper labeling and documentation.
Key characteristics of our QSC Tirzepatide include high purity (99%+), pharmaceutical grade quality, and stable formulation when stored properly. The product should be kept in a cool, dry environment away from light.
For researchers studying metabolic disorders or weight management solutions, QSC Tirzepatide offers an interesting compound to investigate. Its dual agonist properties make it particularly valuable for comparative studies with other GLP-1 receptor agonists.
Please note that this product is for research use only and not intended for human consumption. Proper safety precautions should be followed when handling any research chemicals.